2. Management of the Surgical Patient
4. Pre-exisitng Medical Conditions in Gynaecology Management
7. Sexually Transmitted Infections
10. Mid Trimester Termination of Pregnancy

1.2 Bowel Care
1.3 Enteral Tubes1.2.1 Administration of Aperients
1.2.2 Administration of rectal suppositories
1.2.3 Administration of enema
1.2.4 Bowel Examinations
- Disposable enema
- Tap water enema
- Retention enema (Oil infusion)
1.2.4.1 Colonic Lavage
1.3.1 Insertion of a nasogastric tube
1.3.2 Nasogastric feeding
1.4 Respiratory support
1.4.1 Inhalations
1.4.2 Nebulisations
1.4.3 Oxygen Therapy
1.4.3.1 Nurse / Midwife Initiated Oxygen therapy
1.4.3.2 Nasal prongs
1.4.3.3 Simple mask
1.4.3.4 Non Rebreather Bag and Mask
1.4.3.5 Venturi Mask
1.5 Thoracocentesis
1.5.1 Intercostal Catheter Care
1.5.1.1 Insertion of intercostal catheter and connection to underwater seal drain
1.5.1.2 Ongoing Management of an Intercostal Catheter
1.5.1.3 Changing an ICC Canister
1.6 Vaginal Procedures
1.6.1 Insertion of a Vaginal Pack for Uterine Procedentia
1.6.2 Vaginal Irrigation
2.1.1 Fasting guidelines, refer to Section E
2.1.2 Pre-operative hair removal
2.1.3 Pre-Admission Clinic For Elective Non-Urgent Gynaecology And Urogynaecology Surgery
2.2 Routine Post Operative Care
2.2.1 Receiving patient from recovery
2.2.2 Care following minor surgery for gynaecology,oncology urogynaecology
2.2.2.4 Cervial suture
2.2.3 Major surgery
2.2.3.1 Care following major surgery for gynaecology, oncology,urogynaecology
2.3 Post-operative nausea and vomiting (PONV)
3.1 Pain Control
3.1.1 Types of pain and suggested use of analgesia
3.1.2 Suggested aids to control pain and increase comfort
3.2 Use of nitrous oxide and oxygen inhalation analgesia (Entonox apparatus)
3.3 Epidural narcotic and local anaesthetic analgesia therapy
3.4 Intravenous narcotic infusion
3.4.1 Patient controlled analgesia (PCA)
3.5 Use of ketorolac trometamol
3.6 Local applications
3.6.1 Hot pack
3.6.2 Cold pack
4.1 Anti embolic therapy
4.1.2 Existing therapy requiring special considerations
4.1.3.1 Intravenous heparin therapy
4.1.3.2 Warfarin therapy
4.1.4 Use of anti-embolic stockings/mobilisation
4.1.5 Use of desmopressin
4.1.6 Bibliography
4.2 Diabetes
4.2.1 Diagnoses and therapy
4.2.2 Insulin administration during and after gynaecological surgery for women with Type 1 & Type 2 diabetes
4.2.2.1 Elective surgery
4.2.2.2 Emergency surgery
4.2.3 Management of hypoglycaemia
4.2.4 Management of diabetic ketoacidosis
4.2.5 References
4.3 Cardiac conditions
5.3 Application of stoma appliance
5.6 Stoma irrigation
5.7 Obtaining a urostomy specimen
6.1 Acute pain
6.1.1 Aetiology
- Gynaecologic causes
- Obstetric causes
- Other causes
6.1.2 Clinical assessment
6.1.3 Treatment
6.1.3.1 Acute pelvic inflammatory disease (PID)
6.1.3.2 Ovarian cyst accidents
6.2.1 Treatment
6.2.1.1 Laparoscopy
6.2.1.2 Endometreosis
6.2.1.3 Adhesions
6.2.1.4 Pelvic venous congestion
7.3 Gonorrhoea
7.4 Chlamydia
7.5.1 Genital herpes
7.5.2 Syphillis
8.1 Management and referral for Fertility Services
8.1.1 Referral for IVF
8.2 Aetiology and treatment of infertility
8.2.1 Anovulatory infertility
8.2.2 Tubal infertility
8.2.3 Endometreosis associated infertility
8.2.4 Unexplained infertility
8.2.5 Male factor infertility
8.5 Ovarian Hyperstimulation Syndrome (OHSS)
8.5.1 Inpatient management
9.1 Early pregnancy complications - General considerations
9.1.1 History
9.1.2 Examination
9.1.3 Investigations
9.2.1 Investigations
- BHCG
9.2.2 Treatment
- Algorithm for the management of early pregnancy bleeding
9.2.3 Management of a Woman with Vaginal Bleeding and a Viable Intrauterine Pregnancy
9.3.1 Medical management
9.3.2 Surgical management
9.3.3 References
9.4.1 Interpretation of findings
9.4.2 Medical management using methotrexate
9.4.2.1 Expectant
9.4.2.3 Surgical
9.5 Other early pregnancy complications
9.5.1 Absence of chorionic villi in products of conception
9.5.2 Negative laparoscopy
9.5.3 Molar pregnancy
9.6 Management of hyperemesis gravidarum
9.6.1 Management in the home
9.7 The Kleihauer Test - refer to section A 1.9
9.8 Guidelines for the use of Rh(D) Immunoglobulin (formerly Anti D) - refer to section A 1.9
9.9 Referral to the early Pregnancy Assessment Service
9.10 Management of Early Gestational Sac
10.2 Insertion of an intra-uterine/extra-amniotic Foley's catheter for administration of prostaglandins
10.3 Augmentation of labour using Syntocinon
10.4 Delivery of fetus
10.6 Guidelines for the use of Mifepristone
10.7 Guidelines for the use of Misoprostol
12.1 Management of Menopausal Symptoms (pending)
12.2 Drug Therapy for Relief of Menopausal Symptoms
12.2.1 Hormone Replacement Therapy (HRT) (pending)
12.2.2 Use of androgens in women (pending)
12.3 Management of menopausal symptoms after breast cancer
12.3.1 Options for medication of menopausal symptoms after breast cancer
13.1 Vulvar cancers
13.1.1 Classification and staging of vulvar cancers
13.1.2 Squamous cell carcinoma
- Management of stage 1 and 11
- Management of locally advanced vulvar cancer
- Management of clinically suspicious inguino-femoral nodes
- Management of clinically obvious inguino-femoral nodes
13.2 Cervical cancer
13.2.1 Classification and staging of cervical cancers
13.2.2 Post operative adjuvant therapy
13.2.3 Relative risk of recurrance after hysterectomy for Stage 1 cervical cancer
13.2.4 Locally advanced cervical cancer
13.2.5 Metastatic/recurrant cervical cancer
13.2.6 Special situations
- Adenocarcinoma in situ of the cervix (ACIS)
- Microinvasive adenocarcinoma of the cervix
- Non invasive adenocarcinoma of the cervix
- Small cell neuoendocrine carcinoma
13.2.7 References
13.3 Vaginal cancer
13.3.1 Staging of vaginal carcinoma
13.4 Uterine cancer
13.4.1 Classification and staging of the uterine body
13.4.2 Endometrioid adenocarcinoma Clinical Stage 1
13.4.2.1 Diagnosed after total hysterectomy
13.4.3 Endometrioid adenocarcinoma clinical Stage 2
13.4.3.1 Gross cervical involvement
13.4.3.2 Diagnosed after staging surgery - cervical involvement
13.4.4 Endometrioid adenocarcinoma Clinical Stage 3-4
13.4.4.1 Clinically advanced disease
13.4.4.2 Diagnosed after staging surgery
13.4.4.3 Positive peritoneal washings only
13.4.5 Special situations
13.5 Ovarian cancer
14.2 Pain control in palliative care
14.2.1 Opiod availability and use
14.2.1.1 Initiating morphine
14.2.1.2 Use of methadone
14.2.1.3 Opiod conversions
14.2.2 Use of adjuvant analgaesics
14.2.2.1 Use of Ketamine in cancer pain
14.2.2.3 Graseby Syringe Driver
14.2.3 Management of breakthrough pain (BTP)
14.3 Symptom management
14.3.1 Control of nausea and vomiting
14.3.2 Management of constipation
14.4 Management of acute medical conditions in the setting of terminal illness
14.4.1 Bowel obstruction
14.4.2 Acute renal failure
14.5 Ethical principles of cardiopulmonary resuscitation
14.6 End of life care
15.1 Imaging
15.1.1 Ultrasound examination